Transcript Ben’s presentation

Pediatric Patent Extensions
Ben Peck
Legislative Representative
Public Citizen’s Congress Watch
Revenue to Industry; Costs for Consumers
• $29.6 billion in additional sales over 20
years to brand name drug industry
• $592 million per year in additional profits
for the brand name drug industry
• $14 billion additional drug costs for
consumers over 20 year period
Source: U.S. Food and Drug Administration, “The Pediatric Exclusivity Provision: Status Report to
Congress,” January 2001.
Additional Revenues vs. Cost of Testing
(In Millions)
$1,436
$1,600
$1,292
$1,400
$1,200
$991
$898
$1,000
$772
$800
$570
$584
$633
$662
$705
$600
$400
Prilosec
Lipitor
Prevacid
Prozac
Zocor
Celebrex
Zoloft
Paxil
Claritin
Glucophage
$0
$3.87
Cost of Study
$200
Source: Sales data for year 2000 comes from www.drugtopics.com. Public Citizen calculated added revenues and added
costs to consumers based on a formula used by the U.S. Food and Drug Administration in a January 2001 report to
Drug industry influence
• Senate Sponsors of Pediatric Patent Extension
Legislation, Chistopher Dodd (D-Conn.) and Mike
DeWine (R-Ohio) rank 3rd and 7th in total
contributions from the industry since 1990. Dodd
has received $165,698 and DeWine has received
$132,800.
• Members of the House subcommittee who voted
against reining in giveaway to brand name
industry receive more than twice as much in
campaign contributions from the industry as those
who voted for reining in the giveaway, $65,000 vs.
$25,000 on average since 1990.
Source: Public Citizen analysis of data from the Center for Responsive Politics.
Children’s Groups in a Box
• “This is an incentive that has become such a
windfall for blockbuster drugs,” said Paul Glaser.
“However, as I see it, that is all part and parcel of
buying into our system that stresses money and
power and where there is very little room for
mandating a moral imperative. There is no
choice.”
Paul Glaser, chairman of the Elizabeth Glaser Pediatric AIDS
Foundation (Testimony before the Senate Health Education Labor and
Pensions Committee, May 8, 2001)